|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07J 31/00 | (2006.01) |
| C07J 41/00 | (2006.01) | ||
| A61K 31/567 | (2006.01) | ||
| A61P 5/36 | (2006.01) | ||
| A61K 31/573 | (2006.01) |
| (11) | Number of the document | 3252069 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17176264.4 |
| Date of filing the European patent application | 2010-07-07 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation | 2019-06-10 |
| (30) | Number | Date | Country code |
| 102009034362 | 2009-07-20 | DE |
| (72) |
Schwede, Wolfgang, DE
Klar, Ulrich, DE
Möller, Carsten, DE
Rotgeri, Andrea, DE
Bone, Wilhelm, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | (11.beta.,17.beta.)-17-hidroksi-11-[4-(metilsulfonil)fenil]-17-(pentalfuormetil)estra-4,9-dien-3-onas, skirtas naudoti ligų gydymui |
| (11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULFONYL)PHENYL]-17-(PENTALFUOROMETHYL)ESTRA-4,9-DIEN-3-ONE FOR USE IN THE TREATMENT OF DISEASES |
| Payment date | Validity (years) | Amount | |
| 2022-07-01 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-07-07 |